Your browser doesn't support javascript.
loading
Outcomes after selective nerve root blockade for lumbar radicular pain from lumbar disc hernia or lumbar spinal stenosis assessed by the PROMIS-29 - a prospective observational cohort study.
Karlsson, Caroline; Carlsson, Erik; Åkerstedt, Josefin; Lilja, Petrus; von Essen, Christoffer; Tabatabaei, Pedram; Wänman, Johan.
Afiliação
  • Karlsson C; Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
  • Carlsson E; Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
  • Åkerstedt J; Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
  • Lilja P; Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.
  • von Essen C; Department of Molecular Medicine and Surgery, Stockholm Sports Trauma Research Center, Karolinska Institute, Stockholm, Sweden.
  • Tabatabaei P; Department of Clinical Sciences, Neurosurgery, Umeå University, Umeå, Sweden.
  • Wänman J; Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden. johan.wanman@umu.se.
Acta Neurochir (Wien) ; 166(1): 306, 2024 Jul 25.
Article em En | MEDLINE | ID: mdl-39052107
ABSTRACT

PURPOSE:

Selective nerve root blocks (SNRB) are used both as a therapeutic and diagnostic tool for lumbar radicular pain. Most studies evaluate the effect of SNRB simply by its relation to pain reduction. It is well known that pain is associated with other factors such as depression, anxiety, inactivity and sleeping disorders, but these patient-related outcomes are seldom evaluated. This study evaluated the influence of SNRB on pain-related outcomes including depression, anxiety, fatigue, pain interference, activity and sleep.

METHODS:

One hundred three patients with lumbar radicular pain were treated with a SNRB. Patient-reported outcome measures (PROMs) were assessed with the PROMIS-29 for 12 weeks (84 days) following the SNRB. Patients were stratified based on their pain reduction at the 14-day follow up as responders (≥ 30% pain reduction) and non-responders (< 30% pain reduction). Post-treatment duration was estimated with the Kaplan-Meier analysis with return to baseline as an event. A paired t-test was used to compare pre- and post-treatment responses at specific time intervals.

RESULTS:

Forty-four percent (n = 45) of the patients were responders and showed significant improvement in all parameters throughout the 84-days follow-up, the exception was sleep that lost significance at day 70. The mean post-treatment duration among responders was 59 (52-67) days. Non-responders showed significant improvements in pain interference and pain intensity until day 35 and in ability for social participation until 21-day.

CONCLUSION:

SNRB can improve pain intensity, pain interference, physical function, fatigue, anxiety, depression, sleep disturbance and the ability to participate in social roles.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estenose Espinal / Deslocamento do Disco Intervertebral / Vértebras Lombares / Bloqueio Nervoso Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estenose Espinal / Deslocamento do Disco Intervertebral / Vértebras Lombares / Bloqueio Nervoso Idioma: En Ano de publicação: 2024 Tipo de documento: Article